ArticleEuropean journal of hospital pharmacy : science and practice2023

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19.

Christian Skalafouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.